ID

36964

Description

Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists; ODM derived from: https://clinicaltrials.gov/show/NCT02475057

Link

https://clinicaltrials.gov/show/NCT02475057

Keywords

Versions (2)
  1. 6/24/19 6/24/19 -
  2. 6/24/19 6/24/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 24, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostatic Neoplasms NCT02475057

English

Eligibility Prostatic Neoplasms NCT02475057

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients with locally advanced or metastatic prostate cancer or high-risk prostate cancer.
Description

Gender | Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | High risk Prostate carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0600139
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
UMLS CUI [3]
C0936223
UMLS CUI [4,1]
C0332167
UMLS CUI [4,2]
C0600139
scheduled to start adt for a period of at least one year.
Description

Antiandrogen therapy Scheduled

Data type

boolean

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0205539
subject has a history of one or more of the following:
Description

Patient Criteria

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0243161
1. myocardial infarction
Description

Myocardial Infarction

Data type

boolean

Alias
UMLS CUI [1]
C0027051
2. ischaemic or haemorrhagic cerebrovascular conditions
Description

Ischemic cerebrovascular disease | Hemorrhagic cerebrovascular disease

Data type

boolean

Alias
UMLS CUI [1]
C4478520
UMLS CUI [2]
C4478521
3. arterial embolic and thrombotic events,
Description

Arterial embolus and thrombosis

Data type

boolean

Alias
UMLS CUI [1]
C0155749
4. ischaemic heart disease
Description

Myocardial Ischemia

Data type

boolean

Alias
UMLS CUI [1]
C0151744
5. prior coronary artery or iliofemoral artery revascularization (percutaneous or surgical procedures)
Description

Coronary revascularisation Percutaneous | Coronary revascularisation | Artery iliac femoral Revascularization

Data type

boolean

Alias
UMLS CUI [1,1]
C0877341
UMLS CUI [1,2]
C0522523
UMLS CUI [2]
C0877341
UMLS CUI [3,1]
C0003842
UMLS CUI [3,2]
C0020889
UMLS CUI [3,3]
C0015811
UMLS CUI [3,4]
C0581603
6. peripheral vascular disease (e.g. significant stenosis (abpi<0.9), claudication, prior vascular surgery/intervention)
Description

Peripheral Vascular Disease | Stenosis ABPI | Claudication | Vascular Surgical Procedures | Peripheral Vascular Intervention

Data type

boolean

Alias
UMLS CUI [1]
C0085096
UMLS CUI [2,1]
C1261287
UMLS CUI [2,2]
C1276055
UMLS CUI [3]
C1456822
UMLS CUI [4]
C0042381
UMLS CUI [5]
C3897943
life expectancy of over 12 months.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
who performance status of 0-2
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
subject is able and has agreed to sign a consent form.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior use of adt. however, prior use of anti-androgens such as casodex, chimax, drogenil, and cyprostat will be allowed.
Description

Antiandrogen therapy Previous | Casodex allowed | Chimax allowed | Eulexin allowed | Cyprostat allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0205156
UMLS CUI [2,1]
C0591237
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0595574
UMLS CUI [3,2]
C0683607
UMLS CUI [4,1]
C0591412
UMLS CUI [4,2]
C0683607
UMLS CUI [5,1]
C0591314
UMLS CUI [5,2]
C0683607
prior use of dutasteride/finasteride in past 6 months
Description

Dutasteride | Finasteride

Data type

boolean

Alias
UMLS CUI [1]
C0754659
UMLS CUI [2]
C0060389
known allergic reaction to degarelix.
Description

Allergic Reaction Degarelix

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C1455035
any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule.
Description

Psychological Factors Limiting Protocol Compliance | Factor Familial Limiting Protocol Compliance | Sociological Factors Limiting Protocol Compliance | Geographic Factors Limiting Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0033898
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0525058
UMLS CUI [2,1]
C1521761
UMLS CUI [2,2]
C0241888
UMLS CUI [2,3]
C0439801
UMLS CUI [2,4]
C0525058
UMLS CUI [3,1]
C3850138
UMLS CUI [3,2]
C0439801
UMLS CUI [3,3]
C0525058
UMLS CUI [4,1]
C0017444
UMLS CUI [4,2]
C0439801
UMLS CUI [4,3]
C0525058
Back to the top of the page

Similar models

Eligibility Prostatic Neoplasms NCT02475057

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | High risk Prostate carcinoma
Item
male patients with locally advanced or metastatic prostate cancer or high-risk prostate cancer.
boolean
C0079399 (UMLS CUI [1])
C0600139 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C0936223 (UMLS CUI [3])
C0332167 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
Antiandrogen therapy Scheduled
Item
scheduled to start adt for a period of at least one year.
boolean
C0279492 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Patient Criteria
Item
subject has a history of one or more of the following:
boolean
C0030705 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
Myocardial Infarction
Item
1. myocardial infarction
boolean
C0027051 (UMLS CUI [1])
Ischemic cerebrovascular disease | Hemorrhagic cerebrovascular disease
Item
2. ischaemic or haemorrhagic cerebrovascular conditions
boolean
C4478520 (UMLS CUI [1])
C4478521 (UMLS CUI [2])
Arterial embolus and thrombosis
Item
3. arterial embolic and thrombotic events,
boolean
C0155749 (UMLS CUI [1])
Myocardial Ischemia
Item
4. ischaemic heart disease
boolean
C0151744 (UMLS CUI [1])
Coronary revascularisation Percutaneous | Coronary revascularisation | Artery iliac femoral Revascularization
Item
5. prior coronary artery or iliofemoral artery revascularization (percutaneous or surgical procedures)
boolean
C0877341 (UMLS CUI [1,1])
C0522523 (UMLS CUI [1,2])
C0877341 (UMLS CUI [2])
C0003842 (UMLS CUI [3,1])
C0020889 (UMLS CUI [3,2])
C0015811 (UMLS CUI [3,3])
C0581603 (UMLS CUI [3,4])
Peripheral Vascular Disease | Stenosis ABPI | Claudication | Vascular Surgical Procedures | Peripheral Vascular Intervention
Item
6. peripheral vascular disease (e.g. significant stenosis (abpi<0.9), claudication, prior vascular surgery/intervention)
boolean
C0085096 (UMLS CUI [1])
C1261287 (UMLS CUI [2,1])
C1276055 (UMLS CUI [2,2])
C1456822 (UMLS CUI [3])
C0042381 (UMLS CUI [4])
C3897943 (UMLS CUI [5])
Life Expectancy
Item
life expectancy of over 12 months.
boolean
C0023671 (UMLS CUI [1])
WHO performance status scale
Item
who performance status of 0-2
boolean
C1298650 (UMLS CUI [1])
Informed Consent
Item
subject is able and has agreed to sign a consent form.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antiandrogen therapy Previous | Casodex allowed | Chimax allowed | Eulexin allowed | Cyprostat allowed
Item
prior use of adt. however, prior use of anti-androgens such as casodex, chimax, drogenil, and cyprostat will be allowed.
boolean
C0279492 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0591237 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0595574 (UMLS CUI [3,1])
C0683607 (UMLS CUI [3,2])
C0591412 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
C0591314 (UMLS CUI [5,1])
C0683607 (UMLS CUI [5,2])
Dutasteride | Finasteride
Item
prior use of dutasteride/finasteride in past 6 months
boolean
C0754659 (UMLS CUI [1])
C0060389 (UMLS CUI [2])
Allergic Reaction Degarelix
Item
known allergic reaction to degarelix.
boolean
C1527304 (UMLS CUI [1,1])
C1455035 (UMLS CUI [1,2])
Psychological Factors Limiting Protocol Compliance | Factor Familial Limiting Protocol Compliance | Sociological Factors Limiting Protocol Compliance | Geographic Factors Limiting Protocol Compliance
Item
any psychological, familial, sociological or geographical situation potentially hampering compliance with the study protocol and follow-up schedule.
boolean
C0033898 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C1521761 (UMLS CUI [2,1])
C0241888 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0525058 (UMLS CUI [2,4])
C3850138 (UMLS CUI [3,1])
C0439801 (UMLS CUI [3,2])
C0525058 (UMLS CUI [3,3])
C0017444 (UMLS CUI [4,1])
C0439801 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial